Prognostic factors and treatment of myelodysplastic syndromes.
Mijović
A
A
Institute of Hematology, University Clinical Centre and Medical Faculty, Belgrade, Yugoslavia.
Bosković
D
D
Elezović
I
I
Tomin
D
D
Gotić
M
M
Janosević
S
S
Rolović
Z
Z
D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007962:Leukocytes / Q000201:enzymology; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000145:classification* / Q000188:drug therapy / Q000201:enzymology; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic
D003561:Cytarabine; D000469:Alkaline Phosphatase